Home » Topics » BioWorld Science

BioWorld Science
RSS

DT-0111, a P2X2/3 receptor antagonist for COPD and chronic cough

May 23, 2019

Entyvio approved in Japan for moderate to severely active Crohn's disease

May 23, 2019

New compounds for obesity presented by Ube Industries

May 23, 2019

CC-220 generally well tolerated in pilot study in systemic lupus erythematosus

May 23, 2019

Novartis describes muscarinic M1-M5 receptor ligands

May 23, 2019

GlaxoSmithKline presents new compounds for HIV infections

May 23, 2019

Heptares Therapeutics discloses new orexin OX1 receptor antagonists

May 23, 2019

Bayer patents alpha2B-adrenoceptor antagonists

May 23, 2019

Kangpu initiates first-in-human study of KPG-818 for SLE

May 23, 2019

SAkuraSky study shows satralizumab reduces relapse of neuromyelitis optica in AQP4-IgG+ patients

May 23, 2019

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026